FDA Inspection 1251898 — Analytic Biosurgical Solutions (ABISS)
The FDA completed an inspection of Analytic Biosurgical Solutions (ABISS) on September 12, 2024 in Saint-Etienne. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 12, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Saint-Etienne (France)